Liao Chun-Ta, Chen Hsin-Ni, Wen Yu-Wen, Lee Shu Ru, Ng Shu-Hang, Liu Tsang-Wu, Tsai Sen-Tien, Tsai Ming-Hsui, Lin Jin-Ching, Lou Pei-Jen, Wang Cheng Ping, Chu Pen-Yuan, Leu Yi-Shing, Tsai Kuo-Yang, Terng Shyuang-Der, Chen Tsung-Ming, Wang Cheng-Hsu, Chien Chih-Yen, Chen Wen-Cheng, Lee Li-Yu, Lin Chien-Yu, Wang Hung-Ming, Lin Chih-Hung, Fang Tuan-Jen, Huang Shiang-Fu, Kang Chung-Jan, Chang Kai-Ping, Yang Lan Yan, Yen Tzu-Chen
Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
Nursing Department, Chang Gung Memorial Hospital and School of Nursing, Chang Gung University, Taoyuan, Taiwan.
Eur J Cancer. 2017 Feb;72:226-234. doi: 10.1016/j.ejca.2016.11.010. Epub 2017 Jan 2.
To investigate the association between the diagnosis-to-treatment interval (DTI) and overall survival (OS) in patients with oral cavity squamous cell carcinoma (OSCC).
A total of 18,677 patients with first primary OSCC identified in the Taiwanese Cancer Registry Database between 2004 and 2010 were examined. The effect of DTI on 5-year OS rates was investigated with multivariate Cox regression analysis. After the identification of the optimal cutoff for DTI based on the 5-year OS rates, DTI was classified in the following 20-day groups: ≤20 days (57% of the study patients), 21-45 days (34%), 46-90 days (6%) and ≥91 days (3%). In additional exploratory analyses, DTI was reclassified in the following 30-day interval groups: ≤30 days (81% of the study patients), 31-60 days (14%), 61-90 days (2%) and ≥91 days (3%).
Multivariate analyses identified DTI (≤20 days versus other subgroups), sex (female versus male), age (<65 versus ≥65 years), clinical stage (p-stage I versus p-stage II, III, IV) and treatment modality (initial surgery versus initial non-surgery) as independent prognostic factors for 5-year OS. Compared with a DTI ≤20 days, the DTI categories ≥91 days (hazard ratio [HR]: 1.28, P < 0.001), 46-90 days (HR: 1.25, P < 0.001) and 21-45 days (HR: 1.07, P = 0.007) were independently associated with a higher risk of 5-year mortality. Similar results were obtained for DTI ≤30 days groups.
DTI is independently associated with 5-year OS in OSCC patients. A DTI longer than 30 days or even 20 days may potentially decrease survival.
探讨口腔鳞状细胞癌(OSCC)患者的诊断至治疗间隔(DTI)与总生存期(OS)之间的关联。
对2004年至2010年间在台湾癌症登记数据库中确诊的18677例原发性OSCC患者进行了检查。采用多因素Cox回归分析研究DTI对5年总生存率的影响。根据5年总生存率确定DTI的最佳临界值后,将DTI分为以下20天组:≤20天(占研究患者的57%)、21 - 45天(34%)、46 - 90天(6%)和≥91天(3%)。在额外的探索性分析中,将DTI重新分为以下30天间隔组:≤30天(占研究患者的81%)、31 - 60天(14%)、61 - 90天(2%)和≥91天(3%)。
多因素分析确定DTI(≤20天与其他亚组)、性别(女性与男性)、年龄(<65岁与≥65岁)、临床分期(p分期I与p分期II、III、IV)和治疗方式(初始手术与初始非手术)为5年总生存期的独立预后因素。与DTI≤20天相比,DTI类别≥91天(风险比[HR]:1.28,P < 0.001)、46 - 90天(HR:1.25,P < 0.001)和21 - 45天(HR:1.07,P = 0.007)与5年死亡风险较高独立相关。DTI≤30天组也得到了类似结果。
DTI与OSCC患者5年总生存期独立相关。DTI超过30天甚至20天可能会降低生存率。